1C
XRAY icon

111 Capital’s Dentsply Sirona XRAY Stock Holding History

111 Capital’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164K Buy
+15,482
New +$169K 0.03% 472

Other funds holding XRAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

111 Capital's XRAY Position: Q2 2026 in Review

111 Capital opened a new position in Dentsply Sirona (XRAY) in Q2 2026: 15,482 shares worth $164K. The stake represents 0.03% of the portfolio and ranks #472 among its holdings.

373 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • 111 Capital held 15,482 shares of Dentsply Sirona worth $164K as of Q2 2026.
  • Dentsply Sirona was a new 111 Capital position in Q2 2026.
  • Dentsply Sirona made up 0.03% of 111 Capital's portfolio in Q2 2026, its #472 holding.
  • 373 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.